Takeda (TAK) holder to sell 179,239 ADSs worth about $3.0M

Rhea-AI Filing Summary

A holder of Takeda Pharmaceutical Company Limited American Depositary Shares (ADSs) has filed to sell up to 179,239 ADSs through Interactive Brokers LLC on the NYSE, with a stated aggregate market value of $3,002,257.72. The transaction is referenced with a date of July 13, 2026.

The ADSs relate to Restricted Stock Unit awards that vested on July 1, 2026, categorized as compensation, with 358,730 ADSs shown in connection with those vested awards. No securities sold during the past three months are listed.

Filing Explained

The filing proposes a 358,730-ADS holder sale from vested compensation awards; it does not establish that the sale occurred or that Takeda issued new ADSs.

The July 13, 2026 Form 144 identifies a proposed sale of 358,730 American Depositary Shares (ADSs) for July 1, 2026, but does not report completion; it therefore describes a holder transaction rather than a new issuance by Takeda Pharmaceutical Company Limited.

The securities are described as ADSs acquired through vested restricted stock unit awards and compensation, with the proposed sale date listed as July 1, 2026.

This is a sale with no trading plan disclosed in this filing; the document does not provide a completed-sale confirmation or resulting holdings.

Key Figures

ADSs proposed for sale: 179,239 ADSs Aggregate market value: $3,002,257.72 ADSs tied to vested RSU awards: 358,730 ADSs +2 more

5 metrics

ADSs proposed for sale 179,239 ADSs Maximum Takeda ADSs covered by the sale notice

Aggregate market value $3,002,257.72 Indicated value of 179,239 Takeda ADSs proposed for sale

ADSs tied to vested RSU awards 358,730 ADSs ADSs shown in connection with RSU awards vested on July 1, 2026

RSU vesting date 07/01/2026 Date Restricted Stock Unit awards vested

Proposed sale reference date 07/13/2026 Date associated with the proposed ADS sale

Key Terms

American Depositary Shares (ADSs), Restricted Stock Unit Awards, compensation, NYSE

4 terms

American Depositary Shares (ADSs) financial

"American Depositary Shares (ADSs) | Interactive Brokers LLC"

A U.S.-listed certificate that stands for a specific number of shares in a non‑U.S. company held by a U.S. bank, making the foreign stock tradable on American exchanges in dollars. Think of it like a local voucher that represents ownership of an overseas product — it lets U.S. investors buy and sell foreign companies without handling foreign currency or foreign brokerage accounts, but it can affect dividends, voting rights, fees, liquidity and exposure to currency and regulatory differences.

Restricted Stock Unit Awards financial

"Restricted Stock Unit Awards - Vested."

Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.

compensation financial

"358730 | 07/01/2026 | Compensation"

NYSE financial

"143310556 | 07/13/2026 | NYSE"

A large, regulated marketplace where stocks and other securities are listed and traded, acting like a global auction house that matches buyers and sellers and helps determine share prices. It matters to investors because listing and trading there provide liquidity, price discovery, and regulatory oversight—making it easier to buy or sell holdings and giving companies a visible platform that can affect credibility and access to capital.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 06:30 AM Accepted by SEC EDGAR 07/13/2026 - 06:21 AM Learn about SEC filing dates

FAQ

What does the Form 144 for Takeda (TAK) disclose about ADS sales?

It discloses a plan to sell up to 179,239 American Depositary Shares (ADSs) of Takeda Pharmaceutical Company Limited, with a stated aggregate market value of $3,002,257.72, through a broker on the NYSE.

How many Takeda (TAK) ADSs are tied to vested RSU awards in this Form 144?

The disclosure links 358,730 ADSs to Restricted Stock Unit awards that vested on July 1, 2026, categorized as compensation, providing context for the proposed sale of a portion of those ADSs.

Which broker and exchange are used for the proposed Takeda (TAK) ADS sale?

The ADSs are to be sold through Interactive Brokers LLC, with the securities listed for trading on the New York Stock Exchange (NYSE), according to the disclosure.

What is the indicated market value of Takeda (TAK) ADSs proposed for sale?

The proposed sale covers 179,239 ADSs with an indicated aggregate market value of $3,002,257.72, giving a dollar scale for the potential transaction covered by this Form 144 notice.

What key dates are associated with the Takeda (TAK) Form 144 transaction?

The RSU awards vested on July 1, 2026, and the proposed sale of up to 179,239 ADSs is referenced with a transaction date of July 13, 2026 in the disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich CT 06830	179239	3002257.72	143310556	07/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/01/2026	Restricted Stock Unit Awards - Vested.	Takeda Pharmaceutical Company Limited			358730	07/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)